首页 > 最新文献

Der Urologe. Ausg. A最新文献

英文 中文
Urologie Kolumne. 泌尿科专栏。
Pub Date : 2022-02-01 DOI: 10.1007/s00120-022-01786-8
{"title":"Urologie Kolumne.","authors":"","doi":"10.1007/s00120-022-01786-8","DOIUrl":"https://doi.org/10.1007/s00120-022-01786-8","url":null,"abstract":"","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39906092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[57/m-Increasing pain and penile alterations : Preparation for the medical specialist examination: part 13]. [57/m-增加疼痛和阴茎改变:为医学专家检查做准备:第13部分]。
Pub Date : 2022-02-01 Epub Date: 2021-10-06 DOI: 10.1007/s00120-021-01649-8
Rainer Borowitz, Ulrich Breitkopf
{"title":"[57/m-Increasing pain and penile alterations : Preparation for the medical specialist examination: part 13].","authors":"Rainer Borowitz, Ulrich Breitkopf","doi":"10.1007/s00120-021-01649-8","DOIUrl":"https://doi.org/10.1007/s00120-021-01649-8","url":null,"abstract":"","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39489522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[31/m with hypogonadism and desire to have children : Preparation for the medical specialist examination: part 30]. [31/m性腺功能减退和生育愿望:为医学专家检查做准备:第30部分]。
Pub Date : 2022-02-01 Epub Date: 2021-12-16 DOI: 10.1007/s00120-021-01729-9
Jann-Frederik Cremers
{"title":"[31/m with hypogonadism and desire to have children : Preparation for the medical specialist examination: part 30].","authors":"Jann-Frederik Cremers","doi":"10.1007/s00120-021-01729-9","DOIUrl":"https://doi.org/10.1007/s00120-021-01729-9","url":null,"abstract":"","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39607446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Factors influencing the choice of androgen deprivation therapy for patients with hormone-sensitive prostate cancer : Results of the ProComD study]. [影响激素敏感性前列腺癌患者选择雄激素剥夺治疗的因素:ProComD研究的结果]。
Pub Date : 2022-02-01 DOI: 10.1007/s00120-021-01620-7
J Lehmann, C W Kluike, A Haider, K S Haider, S Baumann, M Flesch, M Gedamke, D Kägebein

Background: Androgen deprivation therapy (ADT) with a GnRH agonist or the GnRH antagonist degarelix is a central component in the treatment of prostate cancer (PCa). Little is currently known regarding the decision criteria. Knowledge of these could improve the success of treatment in the future.

Objectives: To identify factors influencing the treatment decision in patients with hormone-sensitive prostate cancer receiving ADT and to determine the incidence of concomitant disease in both treatment groups.

Methods: The two-arm, prospective, non-interventional study "ProComD" was conducted from September 2014 to June 2019 at 80 study centers in Germany. After the therapy decision was made, patients with hormone-sensitive prostate cancer needing ADT were included in the study. Data were collected during routine visits.

Results: Data from 413 patients were evaluated (degarelix N = 268; GnRH agonists N = 145). Key factors influencing the therapy decision for both treatment options included comorbidities (42% of all patients), compliance (64%), and age (81%). The source of information consulted most frequently regarding existing comorbidities was the patient's medical history conducted by the treating urologist themselves (65% in both groups). For patients with pre-existing cardiovascular diseases, the doctor's letter (45.8% degarelix vs. 38.9% GnRH agonists) or the medical history questionnaire (38.9% degarelix vs. 20% GnRH agonists) was additionally taken into account.

Conclusion: Comorbidities along with age and compliance are among the key factors influencing the treatment decisions made by urologists.

背景:使用GnRH激动剂或GnRH拮抗剂degarelix进行雄激素剥夺治疗(ADT)是前列腺癌(PCa)治疗的核心组成部分。目前对决策标准知之甚少。了解这些可以提高未来治疗的成功率。目的:探讨影响激素敏感性前列腺癌患者接受ADT治疗决策的因素,并确定两组患者的伴随病发生率。方法:2014年9月至2019年6月,在德国80个研究中心进行了两组前瞻性非干预性研究“ProComD”。在做出治疗决定后,需要ADT治疗的激素敏感性前列腺癌患者被纳入研究。在常规访问中收集数据。结果:413例患者的数据被评估(degarelix N = 268;GnRH激动剂N = 145)。影响两种治疗方案的关键因素包括合并症(占所有患者的42%)、依从性(64%)和年龄(81%)。关于现有合并症,最常咨询的信息来源是由泌尿科医生自己提供的患者病史(两组均为65%)。对于已存在心血管疾病的患者,医生的信(45.8%的degarelix对38.9%的GnRH激动剂)或病史问卷(38.9%的degarelix对20%的GnRH激动剂)也被考虑。结论:合并症、年龄和依从性是影响泌尿科医师治疗决策的关键因素。
{"title":"[Factors influencing the choice of androgen deprivation therapy for patients with hormone-sensitive prostate cancer : Results of the ProComD study].","authors":"J Lehmann,&nbsp;C W Kluike,&nbsp;A Haider,&nbsp;K S Haider,&nbsp;S Baumann,&nbsp;M Flesch,&nbsp;M Gedamke,&nbsp;D Kägebein","doi":"10.1007/s00120-021-01620-7","DOIUrl":"https://doi.org/10.1007/s00120-021-01620-7","url":null,"abstract":"<p><strong>Background: </strong>Androgen deprivation therapy (ADT) with a GnRH agonist or the GnRH antagonist degarelix is a central component in the treatment of prostate cancer (PCa). Little is currently known regarding the decision criteria. Knowledge of these could improve the success of treatment in the future.</p><p><strong>Objectives: </strong>To identify factors influencing the treatment decision in patients with hormone-sensitive prostate cancer receiving ADT and to determine the incidence of concomitant disease in both treatment groups.</p><p><strong>Methods: </strong>The two-arm, prospective, non-interventional study \"ProComD\" was conducted from September 2014 to June 2019 at 80 study centers in Germany. After the therapy decision was made, patients with hormone-sensitive prostate cancer needing ADT were included in the study. Data were collected during routine visits.</p><p><strong>Results: </strong>Data from 413 patients were evaluated (degarelix N = 268; GnRH agonists N = 145). Key factors influencing the therapy decision for both treatment options included comorbidities (42% of all patients), compliance (64%), and age (81%). The source of information consulted most frequently regarding existing comorbidities was the patient's medical history conducted by the treating urologist themselves (65% in both groups). For patients with pre-existing cardiovascular diseases, the doctor's letter (45.8% degarelix vs. 38.9% GnRH agonists) or the medical history questionnaire (38.9% degarelix vs. 20% GnRH agonists) was additionally taken into account.</p><p><strong>Conclusion: </strong>Comorbidities along with age and compliance are among the key factors influencing the treatment decisions made by urologists.</p>","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00120-021-01620-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10611945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Use of medical archives for research and patient care]. [利用医学档案进行研究和病人护理]。
Pub Date : 2022-02-01 Epub Date: 2021-12-22 DOI: 10.1007/s00120-021-01742-y
M Peredin, S Baur

In recent years, technology in healthcare has experienced a dynamic increase, with the collection of data being a central component. In particular, artificial intelligence (AI), such as machine learning and deep learning, makes it possible to perform comprehensive analyses of large amounts of data and to draw conclusions based on correlations and pattern recognition. This paper describes the benefits and challenges of big data in patient care.

近年来,医疗保健领域的技术经历了动态增长,数据收集是其核心组成部分。特别是机器学习和深度学习等人工智能(AI),可以对大量数据进行综合分析,并根据相关性和模式识别得出结论。本文描述了大数据在患者护理中的好处和挑战。
{"title":"[Use of medical archives for research and patient care].","authors":"M Peredin,&nbsp;S Baur","doi":"10.1007/s00120-021-01742-y","DOIUrl":"https://doi.org/10.1007/s00120-021-01742-y","url":null,"abstract":"<p><p>In recent years, technology in healthcare has experienced a dynamic increase, with the collection of data being a central component. In particular, artificial intelligence (AI), such as machine learning and deep learning, makes it possible to perform comprehensive analyses of large amounts of data and to draw conclusions based on correlations and pattern recognition. This paper describes the benefits and challenges of big data in patient care.</p>","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39837858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[32/f with lower urinary tract symptoms : Preparation for the medical specialist examination: part 19]. [32/f有下尿路症状:为医学专家检查做准备:第19部分]。
Pub Date : 2022-02-01 Epub Date: 2021-10-06 DOI: 10.1007/s00120-021-01655-w
Tanja Hüsch, André Reitz, Laila Schneidewind, Jennifer Kranz
{"title":"[32/f with lower urinary tract symptoms : Preparation for the medical specialist examination: part 19].","authors":"Tanja Hüsch,&nbsp;André Reitz,&nbsp;Laila Schneidewind,&nbsp;Jennifer Kranz","doi":"10.1007/s00120-021-01655-w","DOIUrl":"https://doi.org/10.1007/s00120-021-01655-w","url":null,"abstract":"","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39489029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[54/m with increasing erectile dysfunction : Preparation for the medical specialist examination: part 29]. [54/m勃起功能障碍增加:准备医学专家检查:第29部分]。
Pub Date : 2022-02-01 Epub Date: 2021-12-16 DOI: 10.1007/s00120-021-01728-w
Herbert Sperling
{"title":"[54/m with increasing erectile dysfunction : Preparation for the medical specialist examination: part 29].","authors":"Herbert Sperling","doi":"10.1007/s00120-021-01728-w","DOIUrl":"https://doi.org/10.1007/s00120-021-01728-w","url":null,"abstract":"","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39607445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Learning from coding data-surgical treatment of benign prostatic syndrome : Big data for BPS]. 【从编码数据中学习——良性前列腺综合征的外科治疗:BPS的大数据】。
Pub Date : 2022-02-01 Epub Date: 2021-12-23 DOI: 10.1007/s00120-021-01739-7
Nadine Binder, J Franz, A Sigle, C Gratzke, A Miernik

Benign prostatic syndrome (BPS) is one of the most common urological diseases. Currently, there are numerous surgical methods to treat BPS. The digitalisation of medicine enables new study approaches in healthcare research using digital data from individual treatment pathways. In the present work, BPS-specific longitudinal trend analyses were performed. Treatment-related figures, both with regard to the therapy methods and predefined patient cohorts, could be examined after validating the datasets. This meant that information on relevant characteristics of surgical BPS treatment could be read and calculations made that reflect the overall impact of these processes. In the future, it is expected that increasingly comprehensive, higher-quality digital datasets on different clinical pictures will be available for analytical purposes. Intensification of research projects in this field is desirable. The results thus obtained enable further optimisation steps of certain treatment actions and provide important key figures for the strategy development of a medical facility.

良性前列腺综合征(BPS)是泌尿系统最常见的疾病之一。目前,有许多手术方法来治疗BPS。医学数字化利用来自个体治疗途径的数字数据,为医疗保健研究提供了新的研究方法。在目前的工作中,进行了bps特定的纵向趋势分析。治疗相关数据,包括治疗方法和预先确定的患者队列,可以在验证数据集后进行检查。这意味着可以读取手术BPS治疗相关特征的信息,并进行计算,以反映这些过程的总体影响。在未来,预计将有越来越全面,更高质量的不同临床图像的数字数据集可用于分析目的。加强这一领域的研究项目是可取的。由此获得的结果能够进一步优化某些治疗行动的步骤,并为医疗设施的战略发展提供重要的关键数据。
{"title":"[Learning from coding data-surgical treatment of benign prostatic syndrome : Big data for BPS].","authors":"Nadine Binder,&nbsp;J Franz,&nbsp;A Sigle,&nbsp;C Gratzke,&nbsp;A Miernik","doi":"10.1007/s00120-021-01739-7","DOIUrl":"https://doi.org/10.1007/s00120-021-01739-7","url":null,"abstract":"<p><p>Benign prostatic syndrome (BPS) is one of the most common urological diseases. Currently, there are numerous surgical methods to treat BPS. The digitalisation of medicine enables new study approaches in healthcare research using digital data from individual treatment pathways. In the present work, BPS-specific longitudinal trend analyses were performed. Treatment-related figures, both with regard to the therapy methods and predefined patient cohorts, could be examined after validating the datasets. This meant that information on relevant characteristics of surgical BPS treatment could be read and calculations made that reflect the overall impact of these processes. In the future, it is expected that increasingly comprehensive, higher-quality digital datasets on different clinical pictures will be available for analytical purposes. Intensification of research projects in this field is desirable. The results thus obtained enable further optimisation steps of certain treatment actions and provide important key figures for the strategy development of a medical facility.</p>","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39637080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
BvDU Kurz notiert. 记得博
Pub Date : 2022-02-01 DOI: 10.1007/s00120-022-01787-7
{"title":"BvDU Kurz notiert.","authors":"","doi":"10.1007/s00120-022-01787-7","DOIUrl":"https://doi.org/10.1007/s00120-022-01787-7","url":null,"abstract":"","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830963/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39906095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Specialist training in urology-the second special issue is available]. [泌尿科专科培训-第二期特刊可供参考]。
Pub Date : 2022-02-01 Epub Date: 2022-02-17 DOI: 10.1007/s00120-022-01772-0
Ulrike Necknig, Maurice Stephan Michel
{"title":"[Specialist training in urology-the second special issue is available].","authors":"Ulrike Necknig,&nbsp;Maurice Stephan Michel","doi":"10.1007/s00120-022-01772-0","DOIUrl":"https://doi.org/10.1007/s00120-022-01772-0","url":null,"abstract":"","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39931893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Der Urologe. Ausg. A
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1